Clinical trial
Can Alendronate Suppress Calcification and Improve Bone Density in Chronic…
NCT00261625 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00261625 |
|---|---|
| Title | Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients? |
| Official title | Can Alendronate Suppress Aortic and Coronary Artery Calcification and Improve Bone Mineral Density in Chronic Peritoneal Dialysis Patients? |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | End-Stage Renal Disease, Osteoporosis |
| Intervention type | Drug |
| Interventions | alendronate |
| Enrollment | 50 |
| Start date | Aug 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Dec 5, 2005 |
| Last update posted | Jan 5, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: